Rexahn Pharmaceuticals, Inc.
http://www.rexahn.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Rexahn Pharmaceuticals, Inc.
RxBar Helps Customers Lose Exes As Nutrition, Wellness Lines Find Target, Whole Foods Shelves
Target adds more than 1,000 wellness products to its shelves; Whole Foods has exclusive deal with InBlooom; and RxBar makes “ultimate breakup gift” promotion.
2023 Review: Chinese-Sponsored Phase III US Trials See Uptick
Companies from China single-handedly sponsored a total of eight Phase III clinical studies that included US sites in 2023 compared to six in 2022 - but the figure was still below the record of 11 in 2021.
LegoChem Brings Late Christmas Cheer With $1.7bn ADC Deal
LegoChem Biosciences has sealed yet another sizable out-licensing agreement with a global big pharma firm, this time with Janssen, underlining the continued keen global interest in ADCs.
CRISPR Overhauls CAR-T Pipeline With Next-Gen Candidates, Autoimmune Expansion
Experts see allogeneic CAR-Ts as less likely to carry potential risks of T-cell malignancies, and an opportunity for differentiation against the crowded autologous CD19-directed CAR-T space.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
-
Drug Delivery
- Site Specific
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
- Nanotechnology, Chips, etc.
-
Drug Discovery Technologies
- Bioinformatics
- Other Names / Subsidiaries
-
- Ocuphire Pharma, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice